EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis

Min-Sik Jo, Hyun-Woo Yang, Joo-Hoo Park iD, Jae-Min Shin iD, Il-Ho Park

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0281640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Min-Sik Jo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Upper Airway Chronic Inflammatory Diseases Laboratory, Korea University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Myofibroblasts, Nasal Polyps. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glycolytic reprogramming is a key feature of chronic inflammatory disease. Extracellular matrix (ECM) produced by myofibroblasts plays an important role in tissue remodeling of nasal mucosa in chronic rhinosinusitis (CRS). This study aimed to determine whether glycolytic reprogramming contributes to myofibroblast differentiation and ECM production in nasal fibroblasts.

Methods

Primary nasal fibroblasts were isolated from the nasal mucosa of patients with CRS. Glycolytic reprogramming was assessed by measuring the extracellular acidification and oxygen consumption rates in nasal fibroblast, with and without transforming growth factor beta 1 (TGF-β1) treatment. Expression of glycolytic enzymes and ECM components was measured by real-time polymerase chain reaction, western blotting, and immunocytochemical staining. Gene set enrichment analysis was performed using whole RNA-sequencing data of nasal mucosa of healthy donors and patients with CRS.

Result

Glycolysis of nasal fibroblasts stimulated with TGF-B1 was upregulated along with glycolytic enzymes. Hypoxia-inducing factor (HIF)-1α was a high-level regulator of glycolysis, and increased HIF-1α expression promoted glycolysis of nasal fibroblasts, and inhibition of HIF-1α down-regulated myofibroblasts differentiation and ECM production.

Conclusion

This study suggests that inhibition of the glycolytic enzyme and HIF-1α in nasal fibroblasts regulates myofibroblast differentiation and ECM generation associated with nasal mucosa remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyofibroblastsNasal PolypsHumansCells, CulturedFibroblastsExtracellular MatrixTransforming Growth Factor beta1Glycolysis

Substanzen

Transforming Growth Factor beta1

Autor:innen und Institutionen

  • Upper Airway Chronic Inflammatory Diseases Laboratory, Korea University College of Medicine, Seoul, South Korea.
  • Medical Device Usability Test Center, Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, South Korea.

ORCID-Profile: Joo-Hoo Park, Jae-Min Shin

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Jo, M. S., Yang, H. W., Park, J. H., Shin, J. M., & Park, I. H. (2023). Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis. PLOS ONE. https://doi.org/10.1371/journal.pone.0281640

Vancouver

Jo MS, Yang HW, Park JH, Shin JM, Park IH. Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis. PLOS ONE. 2023. doi:10.1371/journal.pone.0281640

BibTeX
@article{Jo2023,
  author = {Jo, Min-Sik and Yang, Hyun-Woo and Park, Joo-Hoo and Shin, Jae-Min and Park, Il-Ho},
  title = {Glycolytic reprogramming is involved in tissue remodeling on chronic rhinosinusitis},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0281640}
}
Kostenlos starten →